The complete Transplantation Direct issue for April is now online. In the area of kidney transplantation, studies are presented on how to improve blood pressure control in recipients, and on caution that should be taken when using dd-cfDNA measurements to rule out kidney injury; another article examines perspectives from transplant candidates regarding concerns of receiving an organ during the COVID-19 epidemic. For the liver transplant community, this issue contains articles on critical factors determining the success of transplantation in cases of cholangiocarcinoma and on how pre-transplant hepatitis C treatment affects access to high quality organs. There are also a number of articles on lung transplantation, including studies looking at carfilzomib treatment on antibody-mediated rejection, and examining the effects of ATG treatment on chronic lung allograft dysfunction; also, the association of intragraft hyaluronan levels with acute rejection is examined, and an experimental study in rats is presented testing whether ex vivo perfusion with methylprednisolone protects against brain death-induced injury. In other reports, a study from Asia examines long-term cancer development after pediatric kidney transplantation, and a clinical trial protocol is presented for a randomized trial that seeks to test whether an educational intervention can improve kidney transplantation among waitlisted Blacks. For more details on these articles, please visit our open access Transplantation Direct website.